Page last updated: 2024-09-02

exp3174 and Deep Vein Thrombosis

exp3174 has been researched along with Deep Vein Thrombosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chabielska, E; Gromotowicz-Poplawska, A; Nazarko-Sadowska, J1
Buczko, W; Kucharewicz, I; Matys, T; Pawlak, D; Pawlak, R1

Other Studies

2 other study(ies) available for exp3174 and Deep Vein Thrombosis

ArticleYear
Losartan metabolite EXP3174 reduces the weight of formed thrombus in 2K1C hypertensive rats.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2019, Volume: 70, Issue:3

    Topics: Animals; Antihypertensive Agents; Blood Coagulation; Blood Platelets; Blood Pressure; Hemostasis; Hypertension, Renovascular; Losartan; Male; Platelet Aggregation; Rats; Rats, Wistar; Thrombosis; Venous Thrombosis

2019
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epoprostenol; Fibrinolytic Agents; Hypertension, Renal; Imidazoles; Infusions, Intravenous; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Venous Thrombosis

2002